Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000251675 | SCV000234820 | benign | not specified | 2014-09-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000251675 | SCV000306188 | benign | not specified | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625464 | SCV000745479 | likely benign | Aortic aneurysm, familial thoracic 4 | 2015-05-27 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171277 | SCV001333987 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-11-28 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001195798 | SCV001366218 | uncertain significance | Lissencephaly 4 | 2018-10-31 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence favors the benign nature of this variant, however the evidence is insufficent to prove its benign nature. The following ACMG criteria were applied in classifying this variant: BP6. |
ARUP Laboratories, |
RCV001701548 | SCV001472526 | benign | not provided | 2021-08-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625464 | SCV002406826 | benign | Aortic aneurysm, familial thoracic 4 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000251675 | SCV002819624 | benign | not specified | 2022-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001171277 | SCV004849151 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000625464 | SCV000745964 | likely benign | Aortic aneurysm, familial thoracic 4 | 2014-02-04 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001701548 | SCV001932322 | likely benign | not provided | no assertion criteria provided | clinical testing |